Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024 2024-09-25 13:21
Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan 2024-08-29 13:38
Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab 2024-02-09 11:22
Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe 2023-12-01 03:53
Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule 2023-09-06 19:00
1